This company listing is no longer active
MicroPort CardioFlow Medtech Balance Sheet Health
Financial Health criteria checks 5/6
MicroPort CardioFlow Medtech has a total shareholder equity of CN¥2.2B and total debt of CN¥27.0M, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are CN¥2.5B and CN¥299.8M respectively.
Key information
1.2%
Debt to equity ratio
CN¥27.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.56b |
| Equity | CN¥2.20b |
| Total liabilities | CN¥299.80m |
| Total assets | CN¥2.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2160's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥249.1M).
Long Term Liabilities: 2160's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥50.7M).
Debt to Equity History and Analysis
Debt Level: 2160 has more cash than its total debt.
Reducing Debt: 2160's debt to equity ratio has reduced from 24.3% to 1.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2160 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2160 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.